Analysts expect that Altimmune, Inc. (NYSE:ALT) will report $2.00 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Altimmune’s earnings. The lowest sales estimate is $1.10 million and the highest is $2.90 million. Altimmune posted sales of $580,000.00 during the same quarter last year, which would […]